论文部分内容阅读
中澳合作项目“人参皂甙治疗难治性血液病及对造血相关基因的转录调控”研究,最近获得浙江省中医药科技成果一等奖。这项研究证明了从人参皂甙中分离出的人参二醇是促进造血的有效成分,用其治疗难治性血液病疗效可靠。 目前,国内外治疗难治性血液病普遍采用强的松、雄激素
The Sino-Australian cooperation project “Ginsenosides for the treatment of refractory hematological diseases and transcriptional regulation of hematopoietic related genes” has recently won the first prize for scientific and technological achievements in Zhejiang Province. This study demonstrated that panaxadiol isolated from ginsenosides is an effective ingredient for promoting hematopoiesis, and its efficacy in the treatment of refractory hematological diseases is reliable. At present, prednisone and androgen are commonly used in the treatment of refractory blood diseases at home and abroad.